Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tomáš Kozák
Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group
Klinicka Onkologie
Oncology
Related publications
Treatment of Relapse and Refractory Hodgkin Lymphoma
Oncogematologiya
Oncology
Hematology
Treating Hodgkin Lymphoma in the New Millennium: Relapsed and Refractory Disease
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Role of Cytotoxic and Regulatory T Cells in Relapsed/Refractory Hodgkin Lymphoma
Applied Immunohistochemistry and Molecular Morphology
Forensic Medicine
Pathology
Medical Laboratory Technology
Histology
Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure – Polish Lymphoma Research Group Real-Life Experience
Acta Haematologica Polonica
Oncology
Hematology
Profile of Brentuximab Vedotin and Its Potential in the Treatment of Relapsed or Refractory Hodgkin Lymphoma
Blood and Lymphatic Cancer: Targets and Therapy
Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Annals of Hematology
Medicine
Hematology
Venetoclax (Ven) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma
Blood Reviews
Oncology
Hematology